Clinical Trials Logo

Clinical Trial Summary

Patent Ductus Arteriosus is a developmental condition commonly observed among preterm infants. It is a condition where the opening between the two major blood vessels leading from the heart fail to close after birth. In the womb, the opening (ductus arteriosus) is the normal part of the circulatory system of the baby, but is expected to close at full term birth. If the opening is tiny, the condition can be self-limiting. If not, medications/surgery are options for treatment. There are two ways to treat patent ductus arteriosus - one is through closure of the opening with an FDA approved device called PICCOLO, the other is through supportive management (medications). No randomized controlled trials have been done previously to see if one of better than the other. Through our PIVOTAL study, the investigators aim to determine is one is indeed better than the other - if it is found that the percutaneous closure with PICCOLO is better, then it would immediately lead to a new standard of care. If not, then the investigators avoid an invasive costly procedure going forward.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05547165
Study type Interventional
Source Nationwide Children's Hospital
Contact Carl H Backes
Phone 16143556729
Email carl.backes@nationwidechildrens.org
Status Recruiting
Phase N/A
Start date February 21, 2023
Completion date February 28, 2026

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03604796 - Alternative Paracetamol Treatments for the Neonate With a hsPDA Phase 2/Phase 3
Completed NCT00000494 - Management of Patent Ductus in Premature Infants Phase 3
Completed NCT01251939 - Changes in Renal and Splanchnic Oxygenation During Ibuprofen Treatment for Patent Ductus Arterious N/A
Completed NCT01031316 - Patent Ductus Arteriosus (PDA) Screening Trial N/A
Completed NCT00828334 - NIT-OCCLUD PDA Phase II Sentinel Trial N/A
Completed NCT00009646 - Trial of Indomethacin Prophylaxis in Preterm Infants (TIPP) Phase 3
Withdrawn NCT00470743 - Comparing Ibuprofen And Indomethacin For The Treatment Of The Patent Ductus Arteriosus in Very Premature Babies Phase 4
Completed NCT00725647 - Plasma N-terminal proBNP Concentrations and Patent Ductus Arteriosus in Preterm Babies N/A
Terminated NCT00239512 - New Management Strategy of PDA for VLBW Preterm Infants N/A
Recruiting NCT04508036 - Ductus Arteriosus Closure and D-Dimer and Fibrinogen Levels
Completed NCT01243996 - High-dose Ibuprofen for Patent Ductus Arteriosus (PDA) in Preterm Infant Phase 2/Phase 3
Completed NCT00005190 - Reproduction and Survival After Cardiac Defect Repair N/A
Not yet recruiting NCT04205877 - The U.S. PDA Registry
Completed NCT02422966 - Paracetamol in Patent Ductus Arteriosus Phase 2
Completed NCT02803671 - Analysis of the Impact of Patent Ductus Arteriosus on Brain Function in Preterm Neonates: Multimodal Approach Integrating EEG-NIRS, Ultrasound and Clinical Data N/A
Completed NCT00799123 - Urine NT-proBNP Levels and Echocardiographic Findings in Very Low Birth Weight (VLBW) Infants N/A
Completed NCT00528736 - Plasma B-Type Natriuretic Peptide Concentrations in Preterm Infants < 28 Weeks N/A
Completed NCT02002741 - Adding Paracetamol to Ibuprofen for Treatment of Patent Ductus Arteriosus in Preterm Infants Phase 2/Phase 3